Ozempic, Wegovy, and similar weight loss drugs offer significant health benefits, but covering them for millions of patients could strain insurance budgets. Researchers warn that long-term solutions are needed to ensure safe access to these medications, while emphasizing the potential risks of cheaper, compounded versions.
מקור: Latest Science News — ScienceDaily — לכתבה המלאה
כתיבת תגובה